{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T05:19:47Z","timestamp":1781932787282,"version":"3.54.5"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T00:00:00Z","timestamp":1490227200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["21172202"],"award-info":[{"award-number":["21172202"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Key technology research project of Henan Province","award":["142102310085"],"award-info":[{"award-number":["142102310085"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0174112","type":"journal-article","created":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T19:05:24Z","timestamp":1490295924000},"page":"e0174112","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["FNC efficiently inhibits mantle cell lymphoma growth"],"prefix":"10.1371","volume":"12","author":[{"given":"Yan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixi","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youmei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingduan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbiao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,3,23]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/bjh.12819","article-title":"A multicentre phase II study of vorinostat in patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma","volume":"165","author":"M. Ogura","year":"2014","journal-title":"Br J Haematol"},{"key":"ref2","first-page":"83","article-title":"WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview","volume":"102","author":"E. Sabattini","year":"2010","journal-title":"Pathologica"},{"key":"ref3","first-page":"115","article-title":"Mantle-cell lymphoma","volume":"36","author":"E. Campo","year":"1999","journal-title":"Semin Hematol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11912-015-0460-2","article-title":"Novel agents in mantle cell lymphoma","volume":"17","author":"A. Kumar","year":"2015","journal-title":"Curr Oncol Rep"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1182\/blood-2013-11-531327","article-title":"Randomized trial of bendamustine-rituximab or R-CHOP\/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study","volume":"123","author":"I.W. Flinn","year":"2014","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1182\/blood-2011-09-370320","article-title":"CHOP and DHAP plus rituximab followed by autologous stem cell transplantation in mantle cell lymphoma: a phase 2 study from the Groupe d'Etude des Lymphomes de l'Adulte","volume":"121","author":"R. Delarue","year":"2013","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/ajh.24094","article-title":"Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management","volume":"90","author":"Julie M. Vose","year":"2015","journal-title":"Am. J. Hematol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/978-3-319-13150-4_10","article-title":"Treatment strategies in mantle cell lymphoma","volume":"165","author":"K. Maddocks","year":"2015","journal-title":"Cancer Treat Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1470-2045(02)00788-X","article-title":"Nucleoside analogues and nucleobases in cancer treatment","volume":"3","author":"C.M. Galmarini","year":"2002","journal-title":"Lancet Oncol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/15257770.2013.863334","article-title":"Mechanisms of action of fludarabine nucleoside against human Raji lymphoma cells","volume":"33","author":"R.I. Christopherson","year":"2014","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/leu.2014.284","article-title":"Cytarabine preferentially induces mutation at specific sequences in the genome which are identifiable in relapsed acute myeloid leukaemia","volume":"29","author":"S.E. Fordham","year":"2015","journal-title":"Leukemia"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/COC.0b013e31829e19e0","article-title":"Long-term Survival With Paclitaxel and Gemcitabine for Germ Cell Tumors After Progression Following High-Dose Chemotherapy With Tandem Transplant","volume":"38","author":"B.P. Mulherin","year":"2015","journal-title":"Am J Clin Oncol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/15257770.2013.770523","article-title":"Synthesis of novel nucleoside analogue phosphorothioamidate prodrugs and in vitro anticancer evaluation against RKO human colon carcinoma cells","volume":"32","author":"W. Liu","year":"2013","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.bcp.2011.01.016","article-title":"Effect of its deaminated metabolite, 2',2'-difluorodeoxyuridine, on the transport and toxicity of gemcitabine in HeLa cells","volume":"81","author":"L.S. Hodge","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.bcp.2011.01.001","article-title":"FNC, a novel nucleoside analogue inhibits cell proliferation and tumor growth in a variety of human cancer cells","volume":"81","author":"Q. Wang","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.7314\/APJCP.2014.15.16.6829","article-title":"FNC, a novel nucleoside analogue, blocks invasion of aggressive non-Hodgkin lymphoma cell lines via inhibition of the Wnt\/beta-catenin signaling pathway","volume":"15","author":"Y. Zhang","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref17","first-page":"1460","article-title":"Effect of midazolam on mantle cell lymphoma JeKo-1 cell line and its relevant mechanisms","volume":"21","author":"J.Q. Hong","year":"2013","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.phymed.2010.08.006","article-title":"Apigenin inhibits hepatoma cell growth through alteration of gene expression patterns","volume":"18","author":"J. Cai","year":"2011","journal-title":"Phytomedicine"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.canlet.2012.12.022","article-title":"Comprehensive gene expression profiles of NK cell neoplasms identify vorinostat as an effective drug candidate","volume":"333","author":"K. Karube","year":"2013","journal-title":"Cancer Lett"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/annonc\/mdv102","article-title":"A comprehensive review of lenalidomide therapy for B-cell non-Hodgkin lymphoma","volume":"26","author":"T.E. Witzig","year":"2015","journal-title":"Ann Oncol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood-2010-04-189977","article-title":"Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era","volume":"117","author":"P. Perez-Galan","year":"2011","journal-title":"Blood"},{"key":"ref22","first-page":"183","article-title":"Gambogic acid induces mitochondria-dependent apoptosis by modulation of Bcl-2 and Bax in mantle cell lymphoma JeKo-1 cells","volume":"25","author":"J. Xu","year":"2013","journal-title":"Chin J Cancer Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0092-8674(93)90499-G","article-title":"The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases","volume":"75","author":"J.W. Harper","year":"1993","journal-title":"Cell"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"E4386","DOI":"10.1073\/pnas.1409797111","article-title":"Basal p21 controls population heterogeneity in cycling and quiescent cell cycle states","volume":"111","author":"K.W. Overton","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1186\/bcr3322","article-title":"A novel function for p21Cip1 and acetyltransferase p\/CAF as critical transcriptional regulators of TGFbeta-mediated breast cancer cell migration and invasion","volume":"14","author":"M. Dai","year":"2012","journal-title":"Breast Cancer Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.3892\/or.2013.2786","article-title":"PML overexpression inhibits proliferation and promotes the osteogenic differentiation of human mesenchymal stem cells","volume":"30","author":"J. Sun","year":"2013","journal-title":"Oncol Rep"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0174112","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T23:54:04Z","timestamp":1568937244000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0174112"}},"subtitle":[],"editor":[{"given":"Ramesh","family":"Balusu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,3,23]]},"references-count":26,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0174112","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,23]]}}}